Growth Opportunities and Trends in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the pharmaceutical contract development and manufacturing organization (cmo) market right now?
In recent times, there has been significant growth in the market size of the pharmaceutical contract development and manufacturing organization (CMO). The size is projected to expand from $174.33 billion in 2024 to reach $186.62 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.1%. The market’s growth during the historic period has been spurred by robust economic development in emerging markets, increasing healthcare spending, a rise in pharmaceutical research and development (R&D) expenditure, and a growing inclination towards outsourcing.
How fast Is the pharmaceutical contract development and manufacturing organization (cmo) market expected to grow, and what’s its future value?
Over the coming years, the medium voltage cable market is projected to experience notable growth, and it’s predicted to increase to $45.67 billion in 2029 with a compound annual growth rate (CAGR) of 6.5%. This growth during the anticipated period can be associated with factors such as supply chain dynamics, regulations concerning energy efficiency, government spending, adoption of electric vehicles, and urbanization trends. Key trends that will star during this forecasted period comprise of safety and environmental standards, requirements for resilience and reliability, infrastructure for charging electric vehicles, digitization in the energy sector, and policies on energy transition.
Get your pharmaceutical contract development and manufacturing organization (cmo) market report here!
What are the leading drivers of growth in the pharmaceutical contract development and manufacturing organization (cmo) market?
The expansion of the pharmaceutical contract development and manufacturing market is propelled by the escalating demand for medicines worldwide. The widespread occurrence of illnesses and the desire for extended longevity have surged the necessity for pharmaceuticals, prompting companies in the field to amplify the production of current medicines and escalate their R&D investment for the production of new drugs. This provokes collaboration between pharmaceutical entities and contract manufacturing organizations (CMOs) as a method to reduce operating expenses, leading to a growing demand in the pharmaceutical contract development and manufacturing market. As per Alkermes PLC., a biopharmaceutical firm, pharmaceutical contract manufacturing will rise as a tactical choice for numerous businesses, from larger corporations to smaller specialty pharmaceutical organizations. This is primarily due to pharmaceutical firms seeking ways to reduce costs.
What are the key segments defining the pharmaceutical contract development and manufacturing organization (cmo) market?
The pharmaceutical contract development and manufacturing organization (CMO) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Who are the key players steering the development of the pharmaceutical contract development and manufacturing organization (cmo) market?
Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
What emerging trends are influencing the growth of the pharmaceutical contract development and manufacturing organization (cmo) market?
Pharmaceutical contract development and manufacturing firms are increasingly focusing on securing partnerships and acquisitions with other market players. This trend is driven by a desire to expand their international market presence, cater to client demands effectively, scale up production capabilities whilst ensuring cost-effectiveness, and gain entry into the latest technology and novel services offerings. Such a high rate of merger and acquisition activities is leading to a consolidation of contract service providers. To illustrate, Pharma Nobis, an American company specializing in contract manufacturing and private label services, completed the acquisition of Fagron’s US contract manufacturing operations in July 2022. The amount for this transaction was not disclosed. This move is anticipated to enable Pharma Nobis to supply contract manufacturing and private label services to American retailers and consumer healthcare companies. Fagron will still retain 20% ownership in the company.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2825
Which regions are most influential in expanding the pharmaceutical contract development and manufacturing organization (cmo) market?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Pharmaceutical Drug Delivery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Pharmaceutical Excipients Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Pharmaceutical Logistics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
